Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.

NCT04033991 · clinicaltrials.gov ↗

COMPLETED

Status

684

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma
Renal Cell

Interventions

DRUG: Sunitinib
DRUG: Axitinib

Sponsor

Pfizer